vival 5 mg
actavis group ptc ehf (1) - diazepam - tablett - 5 mg
vival 2 mg
actavis group ptc ehf (1) - diazepam - tablett - 2 mg
mykofenolsyre accord 180 mg
accord healthcare b.v. - mykofenolatnatrium - enterotablett - 180 mg
mykofenolsyre accord 360 mg
accord healthcare b.v. - mykofenolatnatrium - enterotablett - 360 mg
stesolid 5 mg/2.5 ml
orifarm as - diazepam - rektalvæske, oppløsning - 5 mg/2.5 ml
tetmodis 25 mg
aop orphan pharmaceuticals gmbh - tetrabenazin - tablett - 25 mg
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinuri, paroksysmal - immunsuppressive - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
bekemv
amgen technology (ireland) uc - eculizumab - hemoglobinuri, paroksysmal - immunsuppressive - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). dokumentasjon av klinisk nytte er vist hos pasienter med haemolysis med kliniske symptom(s) en indikasjon på høy sykdomsaktivitet, uavhengig av transfusjon historie (se punkt 5..
rativor 1 mg
macure healthcare limited - lorazepam - tablett - 1 mg
rativor 0.5 mg
macure healthcare limited - lorazepam - tablett - 0.5 mg